PMDA Posts Notice on Revision of Precautions for Pharmaceuticals (dated August 28, 2026)
使用上の注意の改訂指示通知（医薬品）2026年8月28日付（厚生労働省より発出）を掲載しました
Published: 2026-08-28 · Source: Pharmaceuticals and Medical Devices Agency (PMDA) — Safety Updates · Stage: Government Announcement · Area: Healthcare / Pharmaceuticals · Impact (preliminary): Medium · First detected by this dashboard: 2026-08-28
View the original Japanese source More Healthcare / Pharmaceuticals updates Search all updates in the dashboard
AI summary
Generated by AI from the Japanese source metadata. It is an unofficial monitoring aid, not legal advice, and may contain errors. The area, stage, and impact labels are preliminary keyword-based triage labels. Confirm every point in the original Japanese source.
Summary
According to the metadata, the PMDA has published a notice concerning instructions to revise the 'Precautions for Use' sections for certain pharmaceuticals, issued by the Ministry of Health, Labour and Welfare and dated August 28, 2026. This appears in the PMDA Safety Updates as a government announcement. The specific products and content of the revisions are not detailed in the provided metadata.
Business Impact
Companies handling affected pharmaceuticals may need to review and update product labeling and safety information to reflect the revised precautions. Related documentation and communications could also be affected.
Recommended Action
Consider reviewing the official PMDA source page to identify which products and specific precaution revisions are involved and verify the details.